Kater AP - Search Results

1

Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment.

Chen Z, Simon-Molas H, Cretenet G, Valle-Argos B, Smith LD, Forconi F, Schomakers BV, van Weeghel M, Bryant DJ, van Bruggen JAC, Peters FS, Rathmell JC, van der Windt GJW, Kater AP, Packham G, Eldering E. Chen Z, et al. Among authors: kater ap. Blood. 2022 Aug 11;140(6):630-643. doi: 10.1182/blood.2021013990. Blood. 2022. PMID: 35486832 Free PMC article.

2

Autologous cytomegalovirus-specific T cells as effector cells in immunotherapy of B cell chronic lymphocytic leukaemia.

Kater AP, Remmerswaal EB, Nolte MA, Eldering E, van Oers MH, van Lier RA. Kater AP, et al. Br J Haematol. 2004 Aug;126(4):512-6. doi: 10.1111/j.1365-2141.2004.05070.x. Br J Haematol. 2004. PMID: 15287944 Free article.

3

Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells.

Dicker F, Kater AP, Fukuda T, Kipps TJ. Dicker F, et al. Among authors: kater ap. Blood. 2005 Apr 15;105(8):3193-8. doi: 10.1182/blood-2003-10-3684. Epub 2004 Aug 31. Blood. 2005. PMID: 15339846 Free article.

4

CD40 stimulation of B-cell chronic lymphocytic leukaemia cells enhances the anti-apoptotic profile, but also Bid expression and cells remain susceptible to autologous cytotoxic T-lymphocyte attack.

Kater AP, Evers LM, Remmerswaal EB, Jaspers A, Oosterwijk MF, van Lier RA, van Oers MH, Eldering E. Kater AP, et al. Br J Haematol. 2004 Nov;127(4):404-15. doi: 10.1111/j.1365-2141.2004.05225.x. Br J Haematol. 2004. PMID: 15521917 Free article.

5

Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation.

Mackus WJ, Kater AP, Grummels A, Evers LM, Hooijbrink B, Kramer MH, Castro JE, Kipps TJ, van Lier RA, van Oers MH, Eldering E. Mackus WJ, et al. Among authors: kater ap. Leukemia. 2005 Mar;19(3):427-34. doi: 10.1038/sj.leu.2403623. Leukemia. 2005. PMID: 15674362

6

Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis.

Kater AP, Dicker F, Mangiola M, Welsh K, Houghten R, Ostresh J, Nefzi A, Reed JC, Pinilla C, Kipps TJ. Kater AP, et al. Blood. 2005 Sep 1;106(5):1742-8. doi: 10.1182/blood-2005-02-0695. Epub 2005 May 24. Blood. 2005. PMID: 15914559 Free PMC article.

7

CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53.

Dicker F, Kater AP, Prada CE, Fukuda T, Castro JE, Sun G, Wang JY, Kipps TJ. Dicker F, et al. Among authors: kater ap. Blood. 2006 Nov 15;108(10):3450-7. doi: 10.1182/blood-2006-04-017749. Epub 2006 Jun 1. Blood. 2006. PMID: 16741250 Free PMC article.

8

Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity.

Smit LA, Hallaert DY, Spijker R, de Goeij B, Jaspers A, Kater AP, van Oers MH, van Noesel CJ, Eldering E. Smit LA, et al. Among authors: kater ap. Blood. 2007 Feb 15;109(4):1660-8. doi: 10.1182/blood-2006-05-021683. Epub 2006 Oct 12. Blood. 2007. PMID: 17038534 Free article.

9

Cellular immune therapy for chronic lymphocytic leukemia.

Kater AP, van Oers MH, Kipps TJ. Kater AP, et al. Blood. 2007 Oct 15;110(8):2811-8. doi: 10.1182/blood-2007-01-068932. Epub 2007 Jul 16. Blood. 2007. PMID: 17638850 Free article. Review.

10

No convincing evidence for a role of CD31-CD38 interactions in the pathogenesis of chronic lymphocytic leukemia.

Tonino SH, Spijker R, Luijks DM, van Oers MH, Kater AP. Tonino SH, et al. Among authors: kater ap. Blood. 2008 Aug 1;112(3):840-3. doi: 10.1182/blood-2008-03-144576. Epub 2008 Jun 2. Blood. 2008. PMID: 18519815 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

220 results

Search Page